A small molecule called ALGERNON2 improved health outcomes in mouse models of neurodegenerative diseases by activating antioxidant pathways in astrocytes.
With a star-shaped drug delivery platform that can stay in the stomach for a week or more, researchers hope to improve medication compliance and overall health.
Researchers discovered that microbial short chain fatty acids influence drug seeking behavior in rats, revealing potential new therapeutic targets for cocaine use disorder.